is retatrutide approved Trial of next-gen weight-loss drug brings it one step closer to FDA approval Retatrutide produces up to 30.3%

Mollan SP, Mytton J, Tsermoulas G, Sinclair AJ

Just as with pharmacies, more information will be coming

2024 Sep 10;2024 doi: 10.1155/2024/9960656

GIP receptor agonism further augments insulin release and may influence fat metabolism, though the precise contribution of GIP receptor activation to clinical outcomes in humans remains an area of active investigation

Feb 28, 2026 Nearly one in four people on GLP-1 medications develop a nutritional deficiency within their first year

[9] [10] The American Society of Anesthesiologists (ASA) and other medical societies have issued guidance on this topic, with updated recommendations in 2024 that move away from blanket cessation toward a more individualized, risk-stratified approach